SCHEMBL20966554

SCHEMBL20966554

CC1OCC(OCc2ccccc2)C(OC2OC(C)[C@@H](OCc3ccccc3)C(OCc3ccccc3)C2OCc2ccccc2)C1OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.43
BCHE P06276 3/20 0.37
SSTR1 P30872 1/20 0.36
SSTR2 P30874 1/20 0.36
SSTR4 P31391 1/20 0.36
SSTR3 P32745 1/20 0.36
SSTR5 P35346 1/20 0.36
ACHE P22303 1/20 0.36
GJB2 P29033 1/20 0.36
FGF1 P05230 2/20 0.36
FGF2 P09038 2/20 0.36
VEGFA P15692 2/20 0.36
HPSE Q9Y251 2/20 0.36
PDPK1 O15530 1/20 0.35
MTOR P42345 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C19 P33261 1/20 0.35
PTPN1 P18031 2/20 0.34
PTPN2 P17706 1/20 0.34
PTPN11 Q06124 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25981819 1.00 SLC6A2 (0.43) SLC6A2BCHESSTR1SSTR2SSTR4
SCHEMBL29870527 0.86 BCHE (0.47) SLC6A2BCHEACHEPDPK1MTOR
SCHEMBL24378345 0.86 BCHE (0.47) SLC6A2BCHEACHEPDPK1MTOR
SCHEMBL18573747 0.86 BCHE (0.47) SLC6A2BCHEACHEPDPK1MTOR
SCHEMBL24378329 0.86 BCHE (0.47) SLC6A2BCHEACHEPDPK1MTOR
SCHEMBL23278551 0.86 BCHE (0.47) SLC6A2BCHEACHEPDPK1MTOR
SCHEMBL24378470 0.86 BCHE (0.47) SLC6A2BCHEACHEPDPK1MTOR
SCHEMBL23817410 0.80 GJB2 (0.45) SLC6A2BCHESSTR1SSTR2SSTR4
SCHEMBL7775231 0.80 PDPK1 (0.45) SLC6A2BCHESSTR1SSTR2SSTR4
SCHEMBL25909886 0.79 BCHE (0.46) SLC6A2BCHEACHEPDPK1MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190127411-A1 GLYCOLIPOPEPTIDE BIOSURFACTANTS CRODA INTERNATIONAL PLC (GB) 2019-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127411-A1 GLYCOLIPOPEPTIDE BIOSURFACTANTS LYPLAL1, LNPEP, PHOSPHO1 SLC6A2 4657/4885BCHE 2066/4885SSTR1 1282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.